ClinicalTrials.Veeva

Menu

Radiomics Multifactorial Biomarker for Pulmonary Nodules (RMBPN)

M

Maastricht University

Status

Completed

Conditions

Lung Neoplasms
Neoplasms
Lung Diseases
Carcinoma, Non-Small-Cell Lung
Pathology

Treatments

Diagnostic Test: radiomics

Study type

Observational

Funder types

Other

Identifiers

NCT03872362
UM2019DLABGY1

Details and patient eligibility

About

The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.

Full description

With the development of computed tomography (CT) equipment and the increasing use of lung cancer screening programs with low-dose CT, a growing number of early-stage lung cancers were detected so that a large number of patients have undergone surgery.

Although a number of radiological studies have been used morphological signs so-called semantic features to make a differential diagnosis, it is still hard to apply by clinician because pulmonary nodules especially ground-glass nodules and small size nodules have atypical radiology signs and have strong subjectivity from different observers. Recently, CT-based radiomics, extracting the quantitative high-throughput features from medical images and facilitating clinical decision-making system, showed a good performance to predict diagnosis and prognosis of diverse cancer.

Therefore, the proposed project aims to develop and validate radiomics models based on CT images to identify malignant nodules and then to discriminate the different types of lung adenocarcinoma in patients with pulmonary nodules.

Enrollment

800 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • intraoperative frozen section diagnosis and final pathology diagnosis are available
  • preoperative standard non-enhanced CT is available
  • Pathologically confirmed

Exclusion criteria

  • with a previous history of radiation therapy, chemotherapy or biopsy
  • the time interval between the CT examination and surgery was more than two weeks

Trial design

800 participants in 3 patient groups

Training dataset
Description:
No interventions
Treatment:
Diagnostic Test: radiomics
External validation1
Description:
No interventions
Treatment:
Diagnostic Test: radiomics
External validation2
Description:
No interventions
Treatment:
Diagnostic Test: radiomics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems